Log in or Sign up for Free to view tailored content for your specialty!
Food Allergy News
Top news of October: Epinephrine nasal spray, cannabis and asthma, cat allergy, more
Healio compiled the most-read news in allergy, asthma and immunology posted in October.
Real-world factors predict tolerance in oral food challenges
Several factors may indicate whether a patient may tolerate an oral food challenge, including patients who may be considered high risk for reactions, according to a study published in Annals of Allergy, Asthma and Immunology.
Log in or Sign up for Free to view tailored content for your specialty!
Q&A: Nasal spray effectively fills need for needleless epinephrine delivery
The neffy epinephrine nasal spray from ARS Pharma produced pharmacokinetic and pharmacodynamic responses that were comparable with injected delivery, according to a study published in The Journal of Allergy and Clinical Immunology.
Sublingual immunotherapy safely, effectively induces peanut allergy remission in toddlers
Sublingual immunotherapy was safe and effective in inducing desensitization and remission of peanut allergy in children aged 1 to 4 years, according to a study published in The Journal of Allergy and Clinical Immunology.
EAACI updates guidelines for diagnosing IgE-mediated food allergy
The European Academy of Allergy and Clinical Immunology has updated its EAACI Guidelines on Food Allergy Diagnosis, targeting patients with IgE-mediated food allergies.
Cashew allergy among infants associated with peanut allergy, eczema
Cashew allergy impacted 1.49% of infants and cashew sensitization impacted 1.96% of infants, both at age 12 months, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.
Allergic reactions rare during commercial flights
Approximately 2% to 3% of in-flight medical events are due to allergic reactions, with approximately 0.7 reactions per million passengers, according to a review published in The Journal of Allergy and Clinical Immunology: In Practice.
FDA schedules Type A meeting to discuss epinephrine nasal spray
The FDA has scheduled a Type A meeting with ARS Pharma to discuss the complete response letter that the FDA previously issued to the company about its new drug application for its neffy epinephrine nasal spray.
Epinephrine nasal spray outcomes comparable with injected delivery
Pharmacokinetic and pharmacodynamic responses to a nasal epinephrine spray were comparable with responses to injected epinephrine, according to a study published in The Journal of Allergy and Clinical Immunology.
Q&A: Study safely increases peptide doses to treat eosinophilic esophagitis
Healthy volunteers taking a first-in-class peptide designed for treating eosinophilic esophagitis did not experience any clinically significant adverse safety findings at any of three evaluated doses, according to a press release.
-
Headline News
A potential new paradigm for treating acute migraine: Timolol nasal spray
November 15, 20245 min read -
Headline News
AI-enabled video of skin on face, hands may detect high blood pressure, diabetes
November 15, 20242 min read -
Headline News
‘Troubling’ data show lack of awareness about lung cancer screening
November 15, 20242 min read
-
Headline News
A potential new paradigm for treating acute migraine: Timolol nasal spray
November 15, 20245 min read -
Headline News
AI-enabled video of skin on face, hands may detect high blood pressure, diabetes
November 15, 20242 min read -
Headline News
‘Troubling’ data show lack of awareness about lung cancer screening
November 15, 20242 min read